IntrinsicIntrinsic
← Scroll for more →

Financial Statements — TTE

Balance Sheet

(in billions USD)
MetricQ4 2025Q2 2025Q4 2024Q2 2024Q4 2023Q2 2023Q4 2022Q2 2022Q4 2021Q2 2021
Cash & Equivalents26.2020.4225.8423.2127.2625.5733.0332.8521.3428.64
Inventory16.6617.2718.8720.1919.3218.7922.9428.5419.9519.16
Total Current Assets89.4790.8596.5791.8099.53104.80125.72155.92111.1487.44
Goodwill12.50--11.27--9.95--8.65--8.83--
Total Non-current Assets201.59201.97188.92187.69184.13176.22178.14177.49182.32185.27
Total Assets291.06292.82285.49279.49283.65281.02303.86333.41293.46272.71
Total Current Liabilities92.5691.2287.9682.3688.7989.74109.78128.6695.1075.18
Total Non-current Liabilities80.9782.6077.2777.1075.4274.8379.5284.7583.3686.95
Total Liabilities*173.53173.82165.23159.46164.20164.57189.29213.41178.46162.13
Total Stockholder Equity117.52119.00120.26120.03119.45116.45114.57120.00115.00110.58
← Scroll for more columns →

* Derived from reported values

Income Statement

(in billions USD) (except per-share rows)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q2 2021
Total Revenue49.6353.7456.2774.7747.05
Total Operating Expenses37.0939.9441.8353.6033.56
Operating Income----6.6013.744.95
Pretax Income*4.856.576.6411.093.91
Tax Provision2.112.732.495.281.61
Net Income2.753.854.155.802.30
Basic EPS1.031.611.512.030.80
Diluted EPS1.171.511.512.160.66
← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in billions USD)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q2 2021
Operating Cash Flow5.969.019.9016.287.55
Investing Cash Flow(6.69)(4.56)(4.47)(4.98)(3.10)
Financing Cash Flow(2.15)(6.82)(7.87)(8.57)(6.30)
← Scroll for more columns →